Evaluation of the Prognostic Factor and the Treatment Efficacy of Inhaled Iloprost in Patients with Group 3 Pulmonary Hypertension

被引：0
|
作者：
Su, P. [1 ]
Hsu, C. [1 ]
机构：
[1] Natl Cheng Kung Univ Hosp, Tainan, Taiwan
来源：
JOURNAL OF HEART AND LUNG TRANSPLANTATION | 2018年 / 37卷 / 04期
关键词：
D O I：
10.1016/j.healun.2018.01.1287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1284
引用
收藏
页码：S493 / S493
页数：1
相关论文
共 50 条
  • [31] Increased neutrophil mediator release in patients with pulmonary hypertension - suppression by inhaled iloprost
    Rose, F
    Hattar, K
    Gakisch, S
    Grimminger, F
    Olschewski, H
    Seeger, W
    Tschuschner, A
    Schermuly, RT
    Weissmann, N
    Hanze, J
    Sibelius, U
    Ghofrani, HA
    THROMBOSIS AND HAEMOSTASIS, 2003, 90 (06) : 1141 - 1149
  • [32] Effect of inhaled iloprost plus oral sildenafil in patients with primary pulmonary hypertension
    Wilkens, H
    Guth, A
    König, J
    Forestier, N
    Cremers, B
    Hennen, B
    Böhm, M
    Sybrecht, GW
    CIRCULATION, 2001, 104 (11) : 1218 - 1222
  • [33] Switching inhaled iloprost formulations in patients with pulmonary arterial hypertension: the VENTASWITCH Trial
    Richter, Manuel J.
    Stollfuss, Barbara
    Roitenberg, Alexander
    Kleinjung, Frank
    Graeff, Valentin
    Berghaus, Sabine
    Mueller, Christian
    Ghofrani, Hossein-Ardeschir
    PULMONARY CIRCULATION, 2018, 8 (04)
  • [34] Influence of inhaled iloprost on transpulmonary gradient of big endothelin in patients with pulmonary hypertension
    Wilkens, H
    Bauer, M
    Forestier, N
    König, J
    Eichler, A
    Schneider, S
    Schäfers, HJ
    Sybrecht, GW
    CIRCULATION, 2003, 107 (11) : 1509 - 1513
  • [35] Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
    Ewert, R.
    Opitz, C. F.
    Wensel, R.
    Winkler, J.
    Halank, M.
    Felix, S. B.
    CLINICAL RESEARCH IN CARDIOLOGY, 2007, 96 (04) : 211 - 217
  • [36] Continuous intravenous iloprost to revert treatment failure of first-line inhaled iloprost therapy in patients with idiopathic pulmonary arterial hypertension
    Ralf Ewert
    Christian F. Opitz
    Roland Wensel
    Jörg Winkler
    Michael Halank
    Stephan B. Felix
    Clinical Research in Cardiology, 2007, 96 : 211 - 217
  • [37] Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: Effects before and after pulmonary thromboendarterectomy
    Kramm, T
    Eberle, B
    Krummenauer, F
    Guth, S
    Oelert, H
    Mayer, E
    ANNALS OF THORACIC SURGERY, 2003, 76 (03): : 711 - 718
  • [38] Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy
    Kramm, T
    Eberle, B
    Guth, S
    Mayer, E
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2005, 28 (06) : 882 - 888
  • [39] Efficacy of inhaled iloprost in children with pulmonary hypertension after pediatric cardiac surgery: a case series
    Arslanoglu, Ergin
    Bakhshaliyev, Shiraslan
    Kara, Kenan Abdurrahman
    Yigit, Fatih
    Yesiltas, Mehmet Ali
    Huseynzade, Shabnam
    Ozalp, Zeynep Gulben Kuk
    Karaci, Ali Riza
    CARDIOTHORACIC SURGEON, 2024, 32 (01):
  • [40] Tolerability and clinical efficacy of inhaled treprostinil in patients with group 1 pulmonary arterial hypertension
    Enderby, Cher Y.
    Burger, Charles
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2018, 9 (09) : 171 - 177
12345